| Year |
Citation |
Score |
| 2023 |
Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37438872 DOI: 10.1002/alz.13382 |
0.329 |
|
| 2023 |
Nelson RS, Abner EL, Jicha GA, Schmitt FA, Di J, Wilcock DM, Barber JM, Van Eldik LJ, Katsumata Y, Fardo DW, Nelson PT. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort. Acta Neuropathologica Communications. 11: 89. PMID 37269007 DOI: 10.1186/s40478-023-01576-z |
0.334 |
|
| 2023 |
Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Medrxiv : the Preprint Server For Health Sciences. PMID 36945447 DOI: 10.1101/2023.03.10.23287109 |
0.322 |
|
| 2022 |
Ashford JW, Schmitt FA, Bergeron MF, Bayley PJ, Clifford JO, Xu Q, Liu X, Zhou X, Kumar V, Buschke H, Dean M, Finkel SI, Hyer L, Perry G. Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. Journal of Alzheimer's Disease : Jad. PMID 35431257 DOI: 10.3233/JAD-220211 |
0.349 |
|
| 2022 |
Karanth SD, Katsumata Y, Nelson PT, Fardo DW, McDowell JK, Schmitt FA, Kryscio RJ, Browning SR, Braithwaite D, Arnold SM, Abner EL. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology. Brain : a Journal of Neurology. PMID 35094057 DOI: 10.1093/brain/awac035 |
0.307 |
|
| 2021 |
Aschenbrenner AJ, Baksh RA, Benejam B, Beresford-Webb JA, Coppus A, Fortea J, Handen BL, Hartley S, Head E, Jaeger J, Levin J, Loosli SV, Rebillat AS, Sacco S, Schmitt FA, et al. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12184. PMID 33969175 DOI: 10.1002/dad2.12184 |
0.335 |
|
| 2021 |
Hendrix JA, Airey DC, Britton A, Burke AD, Capone GT, Chavez R, Chen J, Chicoine B, Costa ACS, Dage JL, Doran E, Esbensen A, Evans CL, Faber KM, Foroud TM, ... ... Schmitt F, et al. Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. Journal of Clinical Medicine. 10. PMID 33924960 DOI: 10.3390/jcm10091907 |
0.33 |
|
| 2020 |
Jiang Y, Li J, Schmitt FA, Jicha GA, Munro NB, Zhao X, Smith CD, Kryscio RJ, Abner EL. Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis. Journal of Alzheimer's Disease : Jad. PMID 33337367 DOI: 10.3233/JAD-200931 |
0.317 |
|
| 2020 |
Van Pelt KL, Koehl L, Caban-Holt A, Anderson-Mooney A, Head E, Schmitt FA. Feasibility of dual-task gait to estimate Alzheimer's related cognitive decline in Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12092. PMID 32875058 DOI: 10.1002/Dad2.12092 |
0.455 |
|
| 2020 |
Bardach SH, Barber JM, Schmitt FA, Van Eldik LJ, Boggess MB, Yarbrough M, Jones KC, Jicha GA. The Effectiveness of Community-based Outreach Events for the Promotion of African American Research Participation. Alzheimer Disease and Associated Disorders. PMID 32809985 DOI: 10.1097/Wad.0000000000000404 |
0.319 |
|
| 2020 |
Katsumata Y, Abner EL, Karanth S, Teylan MA, Mock CN, Cykowski MD, Lee EB, Boehme KL, Mukherjee S, Kauwe JSK, Kryscio RJ, Schmitt FA, Fardo DW, Nelson PT. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy. Acta Neuropathologica. PMID 32797255 DOI: 10.1007/S00401-020-02211-0 |
0.361 |
|
| 2020 |
Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, Cykowski MD, Jicha GA, Van Eldik LJ, Abner EL. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. Jama Neurology. PMID 32568358 DOI: 10.1001/Jamaneurol.2020.1741 |
0.328 |
|
| 2019 |
Moga DC, Beech BF, Abner EL, Schmitt FA, El Khouli RH, Martinez AI, Eckmann L, Huffmyer M, George R, Jicha GA. INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol. Trials. 20: 806. PMID 31888732 DOI: 10.1186/S13063-019-3993-0 |
0.426 |
|
| 2019 |
Rhodus EK, Barber J, Abner EL, Duff DMC, Bardach SH, Caban-Holt A, Lightner D, Rowles GD, Schmitt FA, Jicha GA. Behaviors Characteristic of Autism Spectrum Disorder in a Geriatric Cohort With Mild Cognitive Impairment or Early Dementia. Alzheimer Disease and Associated Disorders. PMID 31517641 DOI: 10.1097/Wad.0000000000000345 |
0.307 |
|
| 2019 |
Brown CA, Schmitt FA, Smith CD, Gold BT. Distinct patterns of default mode and executive control network circuitry contribute to present and future executive function in older adults. Neuroimage. PMID 30953834 DOI: 10.1016/J.Neuroimage.2019.03.073 |
0.374 |
|
| 2019 |
Jicha GA, Kryscio RJ, Beech BF, Wang W, Lynn BC, Schmitt FA, Coy B, Al-Janabi OM, Abner EL, Nelson PT. O3-10-05: MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL Alzheimer's & Dementia. 15: P910-P910. DOI: 10.1016/J.Jalz.2019.06.4682 |
0.312 |
|
| 2019 |
Jiang Y, Li J, Jicha GA, Smith CD, Munro N, Zhao X, Schmitt FA, Kryscio RJ, Abner EL. PROGNOSIS OF CONVERSION TO MILD COGNITIVE IMPAIRMENT AND TIME TO RELIABLE CHANGES VIA MEMORY-RELATED ELECTROPHYSIOLOGICAL BRAIN SIGNATURES Alzheimer's & Dementia. 15: P157. DOI: 10.1016/J.Jalz.2019.06.4322 |
0.349 |
|
| 2019 |
Moga DC, Abner EL, Schmitt FA, Beech BF, Martinez AI, Eckmann L, Huffmyer M, Jicha GA. P4-462: INTERVENTION FOR COGNITIVE RESERVE ENHANCEMENT IN DELAYING THE ONSET OF ALZHEIMER'S SYMPTOMATIC EXPRESSION (INCREASE) STUDY- PROTOCOL AND BASELINE EVALUATION OF PARTICIPANTS Alzheimer's & Dementia. 15: P1480-P1481. DOI: 10.1016/J.Jalz.2019.06.4134 |
0.383 |
|
| 2019 |
Sudduth TL, Abner EL, Kryscio RJ, Cheng Q, Goldstein L, Schmitt FA, Al-Janabi OM, Bahrani AA, Nelson PT, Smith CD, Gold BT, Jicha GA, Wilcock DM. P4-186: ASSESSMENT OF PLASMA AND CSF FOR ANGIOGENIC AND INFLAMMATORY PROTEINS IN A CLINICAL COHORT OF PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA REVEAL POTENTIAL BIOMARKERS OF DISEASE SEVERITY Alzheimer's & Dementia. 15: P1347-P1347. DOI: 10.1016/J.Jalz.2019.06.3848 |
0.402 |
|
| 2019 |
Barber JM, Abner EL, Boggess B, Caban-Holt AM, Jicha GA, Nelson PT, Schmitt FA. P3-472: SEMANTIC CLUSTERING ON THE C.V.L.T.-II IS REDUCED IN COGNITIVELY INTACT OLDER ADULTS WITH AUTOPSY-CONFIRMED ALZHEIMER'S DISEASE NEUROPATHOLOGIC CHANGE Alzheimer's & Dementia. 15: P1148-P1148. DOI: 10.1016/J.Jalz.2019.06.3507 |
0.366 |
|
| 2019 |
Katsumata Y, Abner EL, Kryscio RJ, Schmitt FA, Fardo DW, Nelson PT. P3-438: ASSOCIATIONS BETWEEN TDP-43 PROTEINOPATHY AND COGNITIVE TEST SCORES IN NON-FTLD OLDER ADULTS Alzheimer's & Dementia. 15: P1129-P1130. DOI: 10.1016/J.Jalz.2019.06.3472 |
0.348 |
|
| 2019 |
Martinez AI, Beech BF, Abner EL, Jicha GA, Schmitt FA, Eckmann L, Huffmyer M, Moga DC. P2-572: INAPPROPRIATE MEDICATION USE ASSOCIATED WITH LOWER COGNITIVE RESERVE IN INDIVIDUALS WITH PRE-CLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P842-P842. DOI: 10.1016/J.Jalz.2019.06.2981 |
0.42 |
|
| 2018 |
Helman AM, Siever M, McCarty KL, Lott IT, Doran E, Abner EL, Schmitt FA, Head E. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30452414 DOI: 10.3233/Jad-180589 |
0.432 |
|
| 2018 |
Miranda AM, Herman M, Cheng R, Nahmani E, Barrett G, Micevska E, Fontaine G, Potier MC, Head E, Schmitt FA, Lott IT, Jiménez-Velázquez IZ, Antonarakis SE, Di Paolo G, Lee JH, et al. Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease. Cell Reports. 23: 2967-2975. PMID 29874583 DOI: 10.1016/J.Celrep.2018.05.011 |
0.421 |
|
| 2018 |
Koehl LM, Walls BD, Brothers SL, Morris SN, Glueck AC, Schmitt FA, Berry DTR, Han DY. Convergent and discriminant validity of the Immediate Postconcussion Assessment and Cognitive Testing Battery (ImPACT) in young athletes. Applied Neuropsychology. Child. 1-11. PMID 29465268 DOI: 10.1080/21622965.2018.1436440 |
0.366 |
|
| 2018 |
Broster LS, Li J, Wagner B, Smith CD, Jicha GA, Schmitt FA, Munro N, Haney RH, Jiang Y. Spared behavioral repetition effects in Alzheimer's disease linked to an altered neural mechanism at posterior cortex. Journal of Clinical and Experimental Neuropsychology. 1-16. PMID 29463181 DOI: 10.1080/13803395.2018.1430230 |
0.385 |
|
| 2018 |
Lanzillotta C, Tramutola A, Meier S, Schmitt F, Barone E, Perluigi M, Di Domenico F, Abisambra JF. Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models. Journal of Alzheimer's Disease : Jad. 62: 347-359. PMID 29439332 DOI: 10.3233/Jad-170617 |
0.346 |
|
| 2017 |
Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA, Lott IT. Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathologica Communications. 5: 93. PMID 29195510 DOI: 10.1186/S40478-017-0499-4 |
0.418 |
|
| 2017 |
Ighodaro ET, Nelson PT, Kukull WA, Schmitt FA, Abner EL, Caban-Holt A, Bardach SH, Hord DC, Glover CM, Jicha GA, Van Eldik LJ, Byrd AX, Fernander A. Challenges and Considerations Related to Studying Dementia in African Americans. Journal of Alzheimer's Disease : Jad. PMID 28731440 DOI: 10.3233/Jad-170242 |
0.331 |
|
| 2017 |
Carmona-Iragui M, Balasa M, Benejam B, Alcolea D, Fernández S, Videla L, Sala I, Sánchez-Saudinos MB, Morenas-Rodriguez E, Ribosa-Nogué R, Illán-Gala I, Gonzalez-Ortiz S, Clarimón J, Schmitt F, Powell DK, et al. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28463681 DOI: 10.1016/J.Jalz.2017.03.007 |
0.406 |
|
| 2017 |
LeVine H, Spielmann HP, Matveev S, Cauvi FM, Murphy MP, Beckett TL, McCarty K, Lott IT, Doran E, Schmitt F, Head E. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan. Neurobiology of Aging. PMID 28385551 DOI: 10.1016/J.Jalz.2017.06.474 |
0.346 |
|
| 2017 |
Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA. Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE). Jama Neurology. PMID 28319243 DOI: 10.1001/Jamaneurol.2016.5778 |
0.361 |
|
| 2017 |
Abner EL, Kryscio RJ, Schmitt FA, Fardo DW, Moga DC, Ighodaro ET, Jicha GA, Yu L, Dodge HH, Xiong C, Woltjer RL, Schneider JA, Cairns NJ, Bennett DA, Nelson PT. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Annals of Neurology. PMID 28224671 DOI: 10.1002/Ana.24903 |
0.369 |
|
| 2017 |
Li J, Broster LS, Jicha GA, Munro NB, Schmitt FA, Abner E, Kryscio R, Smith CD, Jiang Y. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimer's Research & Therapy. 9: 3. PMID 28100252 DOI: 10.1186/S13195-016-0229-3 |
0.425 |
|
| 2017 |
Brown CA, Johnson NF, Anderson-Mooney AJ, Jicha GA, Shaw LM, Trojanowski JQ, Van Eldik LJ, Schmitt FA, Smith CD, Gold BT. Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease. Neuroimage. Clinical. 13: 106-115. PMID 27942453 DOI: 10.1016/J.Nicl.2016.11.024 |
0.408 |
|
| 2017 |
Murphy RR, Wells J, Downing E, Uber M, Han DY, Justusson E, Pettigrew LC, Lee JD, Jicha GA, Schmitt FA, Anderson-Mooney AJ. Detection Of Cognitive Impairment After Acute Ischemic Stroke: Validation Of Brief And More Comprehensive Cognitive Screening Instruments And Implications For Best Practice Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1517 |
0.329 |
|
| 2016 |
Dodge HH, Zhu J, Woltjer R, Nelson PT, Bennett DA, Cairns NJ, Fardo DW, Kaye JA, Lyons DE, Mattek N, Schneider JA, Silbert LC, Xiong C, Yu L, Schmitt FA, et al. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28017827 DOI: 10.1016/J.Jalz.2016.11.003 |
0.412 |
|
| 2016 |
Ding X, Kryscio RJ, Turner J, Jicha GA, Cooper G, Caban-Holt A, Schmitt FA, Abner EL. Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial. Journal of the American Geriatrics Society. PMID 27801937 DOI: 10.1111/Jgs.14393 |
0.348 |
|
| 2016 |
Lin AL, Powell D, Caban-Holt A, Jicha G, Robertson W, Gold BT, Davis R, Abner E, Wilcock DM, Schmitt FA, Head E. (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia. Neuroimage. Clinical. 11: 728-35. PMID 27330972 DOI: 10.1016/J.Nicl.2016.06.001 |
0.412 |
|
| 2016 |
Nelson PT, Trojanowski JQ, Abner EL, Al-Janabi OM, Jicha GA, Schmitt FA, Smith CD, Fardo DW, Wang WX, Kryscio RJ, Neltner JH, Kukull WA, Cykowski MD, Van Eldik LJ, Ighodaro ET. "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). Journal of Neuropathology and Experimental Neurology. PMID 27209644 DOI: 10.1093/Jnen/Nlw033 |
0.454 |
|
| 2016 |
Kryscio RJ, Abner EL, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Lou W, Fardo DW, Cooper GE, Schmitt FA. Self-Reported Memory Complaints: A Comparison of Demented and Unimpaired Outcomes. The Journal of Prevention of Alzheimer's Disease. 3: 13-19. PMID 27019842 DOI: 10.1016/J.Jalz.2015.06.312 |
0.303 |
|
| 2016 |
Cykowski MD, Takei H, Van Eldik LJ, Schmitt FA, Jicha GA, Powell SZ, Nelson PT. Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons. Journal of Neuropathology and Experimental Neurology. PMID 26971127 DOI: 10.1093/Jnen/Nlw014 |
0.412 |
|
| 2016 |
Anderson-Mooney AJ, Schmitt FA, Head E, Lott IT, Heilman KM. Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms. Brain and Cognition. 104: 48-57. PMID 26930369 DOI: 10.1016/J.Bandc.2016.02.007 |
0.455 |
|
| 2016 |
Smith CD, Johnson ES, Van Eldik LJ, Jicha GA, Schmitt FA, Nelson PT, Kryscio RJ, Murphy RR, Wellnitz CV. Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease. Brain and Behavior. e00438. PMID 26925303 DOI: 10.1002/Brb3.438 |
0.423 |
|
| 2016 |
Jiang Y, Huang H, Abner E, Broster LS, Jicha GA, Schmitt FA, Kryscio R, Andersen A, Powell D, Van Eldik L, Gold BT, Nelson PT, Smith C, Ding M. Alzheimer's Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States. Frontiers in Aging Neuroscience. 8: 15. PMID 26903858 DOI: 10.3389/Fnagi.2016.00015 |
0.433 |
|
| 2016 |
Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA, Kryscio RJ, Jicha GA, Neltner JH, Monsell SE, Kukull WA, Moser DK, Appiah F, Bachstetter AD, Van Eldik LJ, et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26738751 DOI: 10.1177/0271678X15621574 |
0.407 |
|
| 2016 |
Head E, Fitch JC, Davis PR, Wilcock DM, Schmitt FA. O3-04-05: Frontal Cortex Microhemorrhages in Aging Adults with Down Syndrome: A Potentially Important Contributor to Alzheimer's Disease Pathogenesis Alzheimer's & Dementia. 12: P293-P293. DOI: 10.1016/J.Jalz.2016.06.528 |
0.346 |
|
| 2015 |
Neltner JH, Abner EL, Jicha GA, Schmitt FA, Patel E, Poon LW, Marla G, Green RC, Davey A, Johnson MA, Jazwinski SM, Kim S, Davis D, Woodard JL, Kryscio RJ, et al. Brain pathologies in extreme old age. Neurobiology of Aging. PMID 26597697 DOI: 10.1016/J.Neurobiolaging.2015.10.009 |
0.395 |
|
| 2015 |
Wilcock DM, Schmitt FA, Head E. Cerebrovascular contributions to aging and Alzheimer disease in down syndrome. Biochimica Et Biophysica Acta. PMID 26593849 DOI: 10.1016/J.Bbadis.2015.11.007 |
0.453 |
|
| 2015 |
Wilcock DM, Hurban J, Helman AM, Sudduth TL, McCarty KL, Beckett TL, Ferrell JC, Murphy MP, Abner EL, Schmitt FA, Head E. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Neurobiology of Aging. 36: 2468-74. PMID 26103884 DOI: 10.1016/J.Neurobiolaging.2015.05.016 |
0.402 |
|
| 2015 |
Ighodaro ET, Jicha GA, Schmitt FA, Neltner JH, Abner EL, Kryscio RJ, Smith CD, Duplessis T, Anderson S, Patel E, Bachstetter A, Van Eldik LJ, Nelson PT. Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 74: 642-52. PMID 26083567 DOI: 10.1097/Nen.0000000000000204 |
0.407 |
|
| 2015 |
Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathologica Communications. 3: 32. PMID 26001591 DOI: 10.1186/S40478-015-0209-Z |
0.436 |
|
| 2015 |
Cummings JL, Isaacson RS, Schmitt FA, Velting DM. A practical algorithm for managing Alzheimer's disease: what, when, and why? Annals of Clinical and Translational Neurology. 2: 307-23. PMID 25815358 DOI: 10.1002/Acn3.166 |
0.435 |
|
| 2015 |
Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, ... ... Schmitt F, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2 |
0.422 |
|
| 2015 |
Katsumata Y, Mathews M, Abner EL, Jicha GA, Caban-Holt A, Smith CD, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW. Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort. Dementia and Geriatric Cognitive Disorders. 39: 215-27. PMID 25613081 DOI: 10.1159/000370108 |
0.331 |
|
| 2015 |
McBride JC, Zhao X, Munro NB, Jicha GA, Schmitt FA, Kryscio RJ, Smith CD, Jiang Y. Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease. Neuroimage. Clinical. 7: 258-65. PMID 25610788 DOI: 10.1016/J.Nicl.2014.12.005 |
0.409 |
|
| 2015 |
Di Domenico F, Pupo G, Mancuso C, Barone E, Paolini F, Arena A, Blarzino C, Schmitt FA, Head E, Butterfield DA, Perluigi M. Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1107-20. PMID 25391381 DOI: 10.3233/Jad-141254 |
0.341 |
|
| 2015 |
Scheff SW, Price DA, Ansari MA, Roberts KN, Schmitt FA, Ikonomovic MD, Mufson EJ. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 43: 1073-90. PMID 25147118 DOI: 10.3233/Jad-141518 |
0.429 |
|
| 2015 |
Abner EL, Ding X, Caban-Holt AM, Schmitt FA, Kryscio RJ. P3-262: Comorbid subjective cognitive decline and sleep apnea significantly increase the risk of incident dementia: Results from the prevention of Alzheimer's disease with vitamin e and selenium study Alzheimer's & Dementia. 11: P733-P733. DOI: 10.1016/J.Jalz.2015.06.1635 |
0.403 |
|
| 2014 |
Head E, Schmitt FA. Con: are we ready to translate Alzheimer's disease-modifying therapies to people with down syndrome? Alzheimer's Research & Therapy. 6: 61. PMID 25478026 DOI: 10.1186/S13195-014-0061-6 |
0.411 |
|
| 2014 |
Kryscio RJ, Abner EL, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology. 83: 1359-65. PMID 25253756 DOI: 10.1212/Wnl.0000000000000856 |
0.34 |
|
| 2014 |
Martin SB, Dowling AL, Lianekhammy J, Lott IT, Doran E, Murphy MP, Beckett TL, Schmitt FA, Head E. Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 42: 767-75. PMID 24927707 DOI: 10.3233/Jad-140795 |
0.405 |
|
| 2014 |
Gold BT, Zhu Z, Brown CA, Andersen AH, LaDu MJ, Tai L, Jicha GA, Kryscio RJ, Estus S, Nelson PT, Scheff SW, Abner E, Schmitt FA, Van Eldik LJ, Smith CD. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Neurobiology of Aging. 35: 2263-71. PMID 24866404 DOI: 10.1016/J.Neurobiolaging.2014.04.030 |
0.385 |
|
| 2014 |
Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Frontiers in Genetics. 5: 88. PMID 24795750 DOI: 10.3389/Fgene.2014.00088 |
0.417 |
|
| 2014 |
Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, ... ... Schmitt FA, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica. 127: 825-43. PMID 24770881 DOI: 10.1007/S00401-014-1282-2 |
0.341 |
|
| 2014 |
Mathews M, Abner E, Kryscio R, Jicha G, Cooper G, Smith C, Caban-Holt A, Schmitt FA. Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 675-83. PMID 24656850 DOI: 10.1016/J.Jalz.2013.11.007 |
0.388 |
|
| 2014 |
McBride JC, Zhao X, Munro NB, Smith CD, Jicha GA, Hively L, Broster LS, Schmitt FA, Kryscio RJ, Jiang Y. Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease. Computer Methods and Programs in Biomedicine. 114: 153-63. PMID 24598317 DOI: 10.1016/J.Cmpb.2014.01.019 |
0.443 |
|
| 2014 |
Powell D, Caban-Holt A, Jicha G, Robertson W, Davis R, Gold BT, Schmitt FA, Head E. Frontal white matter integrity in adults with Down syndrome with and without dementia. Neurobiology of Aging. 35: 1562-9. PMID 24582640 DOI: 10.1016/J.Neurobiolaging.2014.01.137 |
0.404 |
|
| 2014 |
Abner EL, Nelson PT, Schmitt FA, Browning SR, Fardo DW, Wan L, Jicha GA, Cooper GE, Smith CD, Caban-Holt AM, Van Eldik LJ, Kryscio RJ. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dementia and Geriatric Cognitive Disorders. 37: 294-306. PMID 24401791 DOI: 10.1159/000355478 |
0.413 |
|
| 2014 |
Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain : a Journal of Neurology. 137: 255-67. PMID 24271328 DOI: 10.1093/Brain/Awt318 |
0.352 |
|
| 2014 |
Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. Journal of Alzheimer's Disease : Jad. 39: 691-702. PMID 24270205 DOI: 10.3233/Jad-131880 |
0.452 |
|
| 2014 |
Rannikmäe K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, Al-Shahi Salman R, Sudlow CL. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 300-5. PMID 24163429 DOI: 10.1136/Jnnp-2013-306485 |
0.308 |
|
| 2014 |
Powell D, Head E, Caban-Holt A, Jicha GA, Robertson W, Davis R, Davis PR, Gold BT, Schmitt FA. P2-015: LOSSES IN FRONTAL WHITE MATTER INTEGRITY IN ADULTS WITH DOWN SYNDROME WITH AND WITHOUT DEMENTIA Alzheimer's & Dementia. 10: P475-P475. DOI: 10.1016/J.Jalz.2014.05.688 |
0.316 |
|
| 2013 |
Farlow MR, Schmitt F, Aarsland D, Grossberg GT, Somogyi M, Meng X. Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders Extra. 3: 281-90. PMID 24174923 DOI: 10.1159/000351861 |
0.469 |
|
| 2013 |
Broster LS, Li J, Smith CD, Jicha GA, Schmitt FA, Jiang Y. Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology. 35: 946-59. PMID 24074205 DOI: 10.1080/13803395.2013.838942 |
0.405 |
|
| 2013 |
Mathews M, Abner E, Caban-Holt A, Dennis BC, Kryscio R, Schmitt F. Quality of education and memory test performance in older men: The New York University paragraph recall test normative data Current Alzheimer Research. 10: 776-783. PMID 23906000 DOI: 10.2174/15672050113109990140 |
0.319 |
|
| 2013 |
Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathologica. 126: 161-77. PMID 23864344 DOI: 10.1007/S00401-013-1154-1 |
0.41 |
|
| 2013 |
Mathews M, Abner E, Caban-Holt A, Kryscio R, Schmitt F. CERAD practice effects and attrition bias in a dementia prevention trial. International Psychogeriatrics. 25: 1115-23. PMID 23570673 DOI: 10.1017/S1041610213000367 |
0.412 |
|
| 2013 |
Kryscio RJ, Abner EL, Lin Y, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 35: 823-32. PMID 23507772 DOI: 10.3233/Jad-122146 |
0.38 |
|
| 2013 |
Scheff SW, Price DA, Schmitt FA, Roberts KN, Ikonomovic MD, Mufson EJ. Synapse stability in the precuneus early in the progression of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 599-609. PMID 23478309 DOI: 10.3233/Jad-122353 |
0.44 |
|
| 2013 |
Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, et al. Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 151-9. PMID 23375564 DOI: 10.1016/J.Jalz.2012.08.008 |
0.402 |
|
| 2013 |
Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiology of Aging. 34: 1051-9. PMID 23062700 DOI: 10.1016/J.Neurobiolaging.2012.09.012 |
0.377 |
|
| 2013 |
Jicha G, Panuganti P, Abner E, Nelson P, Schmitt F, Kryscio R, Van Eldik L, Smith C. P2-118: Neuopathologic substrate of clinically evident, asymmetric, hippocampal atrophy in Alzheimer's disease Alzheimer's & Dementia. 9: P389-P389. DOI: 10.1016/J.Jalz.2013.05.762 |
0.384 |
|
| 2013 |
Jicha G, Nelson P, Fardo D, Kryscio R, Schmitt F, Smith C, Neltner J, Van Eldik L, Kukull W, Abner E. P1-397: Vascular neuropathology in dementia patients receiving antipsychotic therapy Alzheimer's & Dementia. 9: P303-P303. DOI: 10.1016/J.Jalz.2013.05.624 |
0.313 |
|
| 2013 |
Abner E, Schmitt F, Kryscio R, Jicha G, Cooper G, Smith C, Fardo D, Van Eldik L, Gooding L. P4-241: Early-to mid-life formal training in music is associated with improved late-life semantic and episodic memory among cognitively normal older adults Alzheimer's & Dementia. 9: P793-P793. DOI: 10.1016/J.Jalz.2013.05.1633 |
0.313 |
|
| 2013 |
Kryscio R, Abner E, Fardo D, Nelson P, Jicha G, Smith C, Cooper G, Caban-Holt A, Van Eldik L, Schmitt F. P4-178: Self-reported memory decline predicts mild cognitive impairment and dementia Alzheimer's & Dementia. 9: P771-P771. DOI: 10.1016/J.Jalz.2013.05.1569 |
0.379 |
|
| 2013 |
Abner E, Nelson P, Schmitt F, Browning S, Fardo D, Wan L, Jicha G, Cooper G, Smith C, Caban-Holt A, Van Eldik L, Kryscio R. O5-05-04: Self-reported head injury and risk of cognitive impairment and Alzheimer's-type pathology in a longitudinal Alzheimer's disease center cohort Alzheimer's & Dementia. 9: P838-P838. DOI: 10.1016/J.Jalz.2013.04.496 |
0.408 |
|
| 2012 |
Head E, Powell D, Gold BT, Schmitt FA. Alzheimer's Disease in Down Syndrome. European Journal of Neurodegenerative Disease. 1: 353-364. PMID 25285303 |
0.379 |
|
| 2012 |
Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA, Crowley JJ. Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial. Trials. 13: 217. PMID 23171483 DOI: 10.1186/1745-6215-13-217 |
0.357 |
|
| 2012 |
Neltner JH, Abner EL, Schmitt FA, Denison SK, Anderson S, Patel E, Nelson PT. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. Journal of Neuropathology and Experimental Neurology. 71: 1075-85. PMID 23147505 DOI: 10.1097/Nen.0B013E3182768De4 |
0.339 |
|
| 2012 |
Kruger TM, Abner EL, Mendiondo M, Schmitt FA, Smith CD, Jicha GA. Differential reports of pain and depression differentiate mild cognitive impairment from cognitively intact elderly participants. Journal of Geriatric Psychiatry and Neurology. 25: 107-12. PMID 22689703 DOI: 10.1177/0891988712445097 |
0.32 |
|
| 2012 |
Caban-Holt A, Abner E, Kryscio RJ, Crowley JJ, Schmitt FA. Age-expanded normative data for the Ruff 2&7 Selective Attention Test: evaluating cognition in older males. The Clinical Neuropsychologist. 26: 751-68. PMID 22651854 DOI: 10.1080/13854046.2012.690451 |
0.397 |
|
| 2012 |
Abner EL, Kryscio RJ, Cooper GE, Fardo DW, Jicha GA, Mendiondo MS, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Mild cognitive impairment: statistical models of transition using longitudinal clinical data. International Journal of Alzheimer's Disease. 2012: 291920. PMID 22536535 DOI: 10.1155/2012/291920 |
0.42 |
|
| 2012 |
Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ, Caban-Holt A, Lovell MA, Kryscio RJ. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Current Alzheimer Research. 9: 724-33. PMID 22471862 DOI: 10.2174/156720512801322591 |
0.373 |
|
| 2012 |
Cenini G, Dowling AL, Beckett TL, Barone E, Mancuso C, Murphy MP, Levine H, Lott IT, Schmitt FA, Butterfield DA, Head E. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica Et Biophysica Acta. 1822: 130-8. PMID 22009041 DOI: 10.1016/J.Bbadis.2011.10.001 |
0.349 |
|
| 2012 |
Jicha GA, Abner EL, Schmitt FA, Kryscio RJ, Riley KP, Cooper GE, Stiles N, Mendiondo MS, Smith CD, Van Eldik LJ, Nelson PT. Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiology of Aging. 33: 622.e1-622.e16. PMID 21507528 DOI: 10.1016/J.Neurobiolaging.2011.02.018 |
0.482 |
|
| 2012 |
Singhal D, Abner E, Schmitt F, Nelson P, Jicha G. Antipsychotic Use Is Not Associated with an Increased Burden of Cerebrovascular Pathology at Autopsy (S04.004) Neurology. 78: S04.004-S04.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S04.004 |
0.39 |
|
| 2012 |
Singhal D, Hack N, Abner E, Schmitt F, Nelson P, Jicha G. Examining Instability and Reversion in the Diagnosis of Mild Cognitive Impairment (P04.207) Neurology. 78: P04.207-P04.207. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.207 |
0.371 |
|
| 2012 |
Metcalf A, Abner E, Schmitt F, Kryscio R, Stiles N, Jicha G. Frontal Release Signs Predict Decline in Subjects with Intact Cognition and Mild Cognitive Impairment (P01.082) Neurology. 78: P01.082-P01.082. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.082 |
0.366 |
|
| 2012 |
Abner E, Kryscio R, Caban-Holt A, Mathews M, Schmitt F. P2-269: Influence of repeated assessments on the CERAD T-score, a global measure of cognition Alzheimer's & Dementia. 8: P356-P357. DOI: 10.1016/J.Jalz.2012.05.977 |
0.325 |
|
| 2012 |
Head E, Davis R, Caban-Holt A, Dennis B, Jicha G, Powell D, Abner E, Dowling AL, Gold B, Wyss-Coray T, Schmitt F. P2-267: A longitudinal study of aging and the development of Alzheimer's disease in people with Down syndrome Alzheimer's & Dementia. 8: P355-P356. DOI: 10.1016/J.Jalz.2012.05.975 |
0.394 |
|
| 2012 |
Jicha G, Singhal D, Hack N, Abner E, Schmitt F, Kryscio R. O2-13-05: Reversion from mild cognitive impairment to cognitively intact is associated with medically reversible causes for cognitive decline rather than overt instability in the diagnosis of mild cognitive impairment Alzheimer's & Dementia. 8: P263-P263. DOI: 10.1016/J.Jalz.2012.05.700 |
0.361 |
|
| 2012 |
Abner E, Schmitt F, Caban-Holt A, Dennis B, Mathews M, Cooper G, Jicha G, Ranseen J, Mendiondo M, Kryscio R. P1-108: Dual cognitive screening for dementia: Preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADViSE) trial Alzheimer's & Dementia. 8: P144-P144. DOI: 10.1016/J.Jalz.2012.05.385 |
0.393 |
|
| 2011 |
Ferris SH, Schmitt FA, Saxton J, Richardson S, Mackell J, Sun Y, Xu Y. Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease. Alzheimer's Research & Therapy. 3: 22. PMID 21689411 DOI: 10.1186/Alzrt84 |
0.383 |
|
| 2011 |
Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain : a Journal of Neurology. 134: 1506-18. PMID 21596774 DOI: 10.1093/Brain/Awr053 |
0.384 |
|
| 2011 |
Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathologica. 121: 571-87. PMID 21516511 DOI: 10.1007/S00401-011-0826-Y |
0.446 |
|
| 2011 |
Riley KP, Jicha GA, Davis D, Abner EL, Cooper GE, Stiles N, Smith CD, Kryscio RJ, Nelson PT, Van Eldik LJ, Schmitt FA. Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. Journal of Alzheimer's Disease : Jad. 25: 707-17. PMID 21498903 DOI: 10.3233/Jad-2011-102133 |
0.469 |
|
| 2011 |
Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson PT. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? Journal of Alzheimer's Disease : Jad. 25: 445-53. PMID 21471646 DOI: 10.3233/Jad-2011-101980 |
0.426 |
|
| 2011 |
Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT. Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. International Journal of Geriatric Psychiatry. 26: 356-63. PMID 21312297 DOI: 10.1002/Gps.2534 |
0.423 |
|
| 2011 |
Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 24: 547-57. PMID 21297265 DOI: 10.3233/Jad-2011-101782 |
0.46 |
|
| 2011 |
Head E, Doran E, Nistor M, Hill M, Schmitt FA, Haier RJ, Lott IT. Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome. Journal of Alzheimer's Disease : Jad. 23: 399-409. PMID 21116050 DOI: 10.3233/Jad-2010-101335 |
0.392 |
|
| 2010 |
Grossberg GT, Schmitt FA, Xiangyi Meng, Tekin S, Olin J. Effects of transdermal rivastigmine on ADAS-Cog items in mild-to-moderate Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias. 25: 627-633. PMID 21131668 DOI: 10.1177/1533317510385808 |
0.418 |
|
| 2010 |
McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 482-93. PMID 21044778 DOI: 10.1016/J.Jalz.2009.09.004 |
0.436 |
|
| 2010 |
Schmitt FA, Farlow MR, Meng X, Tekin S, Olin JT. Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia. Cns Neuroscience & Therapeutics. 16: 330-6. PMID 20950329 DOI: 10.1111/J.1755-5949.2010.00182.X |
0.402 |
|
| 2010 |
Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD, Van Eldik LJ, Markesbery WR. Association between male gender and cortical Lewy body pathology in large autopsy series. Journal of Neurology. 257: 1875-81. PMID 20563821 DOI: 10.1007/S00415-010-5630-4 |
0.372 |
|
| 2010 |
Schmitt FA, Aarsland D, Brønnick KS, Meng X, Tekin S, Olin JT. Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. American Journal of Alzheimer's Disease and Other Dementias. 25: 407-13. PMID 20392860 DOI: 10.1177/1533317510367486 |
0.427 |
|
| 2010 |
Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. Journal of Neurology. 257: 359-66. PMID 19795154 DOI: 10.1007/S00415-009-5324-Y |
0.448 |
|
| 2010 |
Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery WR. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiology of Aging. 31: 1805-13. PMID 19026468 DOI: 10.1016/J.Neurobiolaging.2008.09.017 |
0.369 |
|
| 2010 |
Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Davis DG, Poduska JW, Patel E, Mendiondo MS, Markesbery WR. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathology (Zurich, Switzerland). 20: 66-79. PMID 19021630 DOI: 10.1111/J.1750-3639.2008.00244.X |
0.463 |
|
| 2010 |
Kruger TM, Abner E, Schmitt FA, Jicha GA. O1-05-04: Pain and depression in normal cognitive aging and mild cognitive impairment Alzheimer's & Dementia. 6: S79-S79. DOI: 10.1016/J.Jalz.2010.05.236 |
0.334 |
|
| 2009 |
Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, Peterson SL, Schmitt FA, Markesbery WR, Liu Q, Crook JE, Younkin SG, Bu G, Estus S. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Molecular Neurodegeneration. 4: 46. PMID 19889229 DOI: 10.1186/1750-1326-4-46 |
0.37 |
|
| 2009 |
Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Disease and Associated Disorders. 23: 260-7. PMID 19812469 DOI: 10.1097/Wad.0B013E31819Cb760 |
0.392 |
|
| 2009 |
Nelson PT, Kryscio RJ, Jicha GA, Abner EL, Schmitt FA, Xu LO, Cooper G, Smith CD, Markesbery WR. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology. 73: 1127-33. PMID 19805729 DOI: 10.1212/Wnl.0B013E3181Bacf9E |
0.393 |
|
| 2009 |
Schmitt FA, Saxton JA, Xu Y, McRae T, Sun Y, Richardson S, Li H. A brief instrument to assess treatment response in the patient with advanced alzheimer disease Alzheimer Disease and Associated Disorders. 23: 377-383. PMID 19571727 DOI: 10.1097/Wad.0B013E3181Ac9Cc1 |
0.399 |
|
| 2009 |
Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Santacruz K, Smith CD, Patel E, Markesbery WR. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 68: 774-84. PMID 19535994 DOI: 10.1097/Nen.0B013E3181Aacbe9 |
0.411 |
|
| 2009 |
Markesbery WR, Jicha GA, Liu H, Schmitt FA. Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology. 68: 816-22. PMID 19535990 DOI: 10.1097/Nen.0B013E3181Ac10A7 |
0.411 |
|
| 2009 |
Price JL, McKeel DW, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging. 30: 1026-36. PMID 19376612 DOI: 10.1016/J.Neurobiolaging.2009.04.002 |
0.493 |
|
| 2009 |
Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR. Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. Journal of Alzheimer's Disease : Jad. 16: 29-34. PMID 19158418 DOI: 10.3233/Jad-2009-0926 |
0.466 |
|
| 2009 |
Hoffmann M, Schmitt F, Bromley E. Comprehensive cognitive neurological assessment in stroke. Acta Neurologica Scandinavica. 119: 162-71. PMID 19053949 DOI: 10.1111/J.1600-0404.2008.01101.X |
0.303 |
|
| 2009 |
Nelson PT, Abner EL, Scheff SW, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Patel E, Markesbery WR. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neuroscience Letters. 450: 336-9. PMID 19010392 DOI: 10.1016/J.Neulet.2008.11.006 |
0.421 |
|
| 2009 |
Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, Davis GJ, Keller JN, Jicha GA, Davis D, Wang-Xia W, Hartman A, Katz DG, Markesbery WR. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochimica Et Biophysica Acta. 1792: 454-69. PMID 18789386 DOI: 10.1016/J.Bbadis.2008.08.005 |
0.305 |
|
| 2009 |
Jicha GA, Abner E, Schmitt FA, Markesbery WR. P4-096: Preclinical Alzheimer's disease cannot be reliably identified in the antemortem setting using standard clinical and neuropsychological test measures Alzheimer's & Dementia. 5: P459-P459. DOI: 10.1016/J.Jalz.2009.04.865 |
0.383 |
|
| 2009 |
Schmitt FA, Kryscio RJ, Xu L, Mendiondo M, Caban-Holt A, Abner E, Runyons C, Markesbery WR. P1-277: Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial Alzheimer's & Dementia. 5: P258-P258. DOI: 10.1016/J.Jalz.2009.04.285 |
0.338 |
|
| 2008 |
Dassel KB, Schmitt FA. The impact of caregiver executive skills on reports of patient functioning. The Gerontologist. 48: 781-92. PMID 19139251 DOI: 10.1093/Geront/48.6.781 |
0.413 |
|
| 2008 |
Jicha GA, Abner E, Carr S, Schmitt F, Markesbery W. P1-162: Mild cognitive impairment in two distinct clinical populations: Acceptance of diagnosis, medical causes, and cognitive profiles Alzheimer's & Dementia. 4: T255-T255. DOI: 10.1016/J.Jalz.2008.05.750 |
0.369 |
|
| 2008 |
Schmitt FA, Caban-Holt A, Abner EL, Runyons C, Kryscio R, Mendiondo M, Markesbery WR. P4-393: Memory screening validation for Alzheimer prevention trials: The prevention of Alzheimer's disease by vitamin E and selenium (PREADVISE) study Alzheimer's & Dementia. 4: T789-T790. DOI: 10.1016/J.Jalz.2008.05.2463 |
0.376 |
|
| 2008 |
Scheff SW, Price DA, Schmitt FA, Mufson EJ. P4-158: Preservation of synaptic numbers in the precuneus associated with mild cognitive impairment and mild-to-moderate Alzheimer's disease Alzheimer's & Dementia. 4: T716-T717. DOI: 10.1016/J.Jalz.2008.05.2225 |
0.43 |
|
| 2008 |
Jicha GA, Abner E, Schmitt FA, Nelson PT, Davis D, Markesbery WR. P4-155: Preclinical Alzheimer's disease in a large autopsy series of longitudinally studied, cognitively normal control subjects Alzheimer's & Dementia. 4: T715-T716. DOI: 10.1016/J.Jalz.2008.05.2222 |
0.433 |
|
| 2008 |
Mendiondo MS, Kryscio RJ, Abner EL, Caban-Holt AM, Runyons C, Markesbery WR, Schmitt FA. P3-159: Practice effects: Factors associated with repeated memory impairment screen scores in the antioxidant Alzheimer's disease prevention (PREADVISE) trial Alzheimer's & Dementia. 4: T566-T567. DOI: 10.1016/J.Jalz.2008.05.1725 |
0.388 |
|
| 2007 |
Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H, Fillit H. Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 75-80. PMID 19595920 DOI: 10.1016/J.Jalz.2007.03.005 |
0.372 |
|
| 2007 |
Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, Abner EL, Markesbery WR. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. Journal of Neuropathology and Experimental Neurology. 66: 1136-46. PMID 18090922 DOI: 10.1097/Nen.0B013E31815C5Efb |
0.471 |
|
| 2007 |
Weycker D, Taneja C, Edelsberg J, Erder MH, Schmitt FA, Setyawan J, Oster G. Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Current Medical Research and Opinion. 23: 1187-97. PMID 17519086 DOI: 10.1185/030079907X188071 |
0.373 |
|
| 2007 |
Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR. The HIV Dementia Scale: predictive power in mild dementia and HAART. Journal of the Neurological Sciences. 260: 11-5. PMID 17482212 DOI: 10.1016/J.Jns.2006.03.023 |
0.303 |
|
| 2007 |
Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, Markesbery WR. Brain structural alterations before mild cognitive impairment. Neurology. 68: 1268-73. PMID 17438217 DOI: 10.1212/01.Wnl.0000259542.54830.34 |
0.324 |
|
| 2007 |
Bottiggi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, Schmitt FA. Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 15: 357-9. PMID 17384320 DOI: 10.1097/Jgp.0B013E31802Dd354 |
0.377 |
|
| 2007 |
Schmitt F, Ryan M, Cooper G. A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease. Expert Opinion On Drug Metabolism & Toxicology. 3: 135-41. PMID 17269900 DOI: 10.1517/17425255.3.1.135 |
0.405 |
|
| 2007 |
Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiology of Aging. 28: 1075-87. PMID 16774798 DOI: 10.1016/J.Neurobiolaging.2006.05.018 |
0.32 |
|
| 2007 |
Salazar JC, Schmitt FA, Yu L, Mendiondo MM, Kryscio RJ. Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Statistics in Medicine. 26: 568-80. PMID 16345024 DOI: 10.1002/Sim.2437 |
0.396 |
|
| 2007 |
Schmitt FA, Kryscio RJ, Caban-Holt A, Abner EL, Runyons C, Mendiondo M, Bottigi K, Markesbery WR. P-118: Concordance of MIS and CERAD screening in the preadvise antioxidant AD prevention trial Alzheimer's & Dementia. 3: S136-S136. DOI: 10.1016/J.Jalz.2007.04.182 |
0.323 |
|
| 2007 |
Schmitt FA, Kryscio RJ, Abner EL, Mendiondo MS, Runyons C, Caban-Holt A, Markesbery WR. P-200: Factors associated with practice effects and decline in MIS scores in the preadvise antioxidant Alzheimer's disease prevention trial Alzheimer's & Dementia. 3: S162-S162. DOI: 10.1016/J.Jalz.2007.04.163 |
0.388 |
|
| 2006 |
Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H. Should older adults be screened for dementia? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 76-85. PMID 19595860 DOI: 10.1016/J.Jalz.2006.02.005 |
0.344 |
|
| 2006 |
Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Disease and Associated Disorders. 20: S124-38. PMID 17135806 DOI: 10.1097/01.Wad.0000213878.47924.44 |
0.331 |
|
| 2006 |
Feldman HH, Schmitt FA, Olin JT. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Alzheimer Disease and Associated Disorders. 20: 263-8. PMID 17132971 DOI: 10.1097/01.Wad.0000213859.35355.59 |
0.407 |
|
| 2006 |
Schmitt FA, van Dyck CH, Wichems CH, Olin JT. Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. Alzheimer Disease and Associated Disorders. 20: 255-62. PMID 17132970 DOI: 10.1097/01.Wad.0000213860.35355.D4 |
0.424 |
|
| 2006 |
Bottiggi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, Mendiondo MS, Schmitt FA. Long-term cognitive impact of anticholinergic medications in older adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 980-4. PMID 17068321 DOI: 10.1097/01.Jgp.0000224619.87681.71 |
0.342 |
|
| 2006 |
Schmitt FA, Wichems CH. A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. Primary Care Companion to the Journal of Clinical Psychiatry. 8: 158-9. PMID 16912819 DOI: 10.4088/Pcc.V08N0306 |
0.41 |
|
| 2006 |
Mitchell DB, Schmitt FA. Short- and long-term implicit memory in aging and Alzheimer's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 13: 611-35. PMID 16887792 DOI: 10.1080/13825580600697616 |
0.408 |
|
| 2006 |
van Dyck CH, Schmitt FA, Olin JT. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 428-37. PMID 16670247 DOI: 10.1097/01.Jgp.0000203151.17311.38 |
0.429 |
|
| 2006 |
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Archives of Neurology. 63: 49-54. PMID 16401736 DOI: 10.1001/Archneur.63.1.49 |
0.383 |
|
| 2006 |
Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Archives of Neurology. 63: 38-46. PMID 16401735 DOI: 10.1001/Archneur.63.1.38 |
0.396 |
|
| 2006 |
Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 27: 1372-84. PMID 16289476 DOI: 10.1016/J.Neurobiolaging.2005.09.012 |
0.376 |
|
| 2006 |
Bottiggi KA, Mendiondo M, Mattingly M, Smith C, Cooper G, Jicha G, Schmitt F. The Influence of Literacy on Cognitive Functioning in Unimpaired Older Adults, Mild Cognitive Impairment, and Dementia Alzheimer Disease & Associated Disorders. 20: S101. DOI: 10.1097/00002093-200607001-00019 |
0.386 |
|
| 2006 |
Schmitt FA, Tariot PN, Grossberg GT, Hendrix S, Ellison N, Kerolous M. P2-002: SIB MAINTENANCE OF RESPONSE WITH MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS: POOLED POST HOC ANALYSIS OF 2 RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE AD Alzheimer's & Dementia. 14: P665-P665. DOI: 10.1016/J.Jalz.2018.06.686 |
0.36 |
|
| 2006 |
Barber JM, Beech BF, Jicha GA, Caban-Holt AM, Schmitt FA. P1-506: CSF MARKERS OF PRECLINICAL ALZHEIMER'S AND DEFICITS ON A SELF-ADMINISTERED COMPUTERIZED TEST BATTERY Alzheimer's & Dementia. 14: P523-P524. DOI: 10.1016/J.Jalz.2018.06.517 |
0.337 |
|
| 2006 |
Mendiondo MS, Kryscio RJ, Schmitt FA, Core UC. P2-072: Antioxidant use at enrollment predicts transitions from normal to amnestic MCI and dementia Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.909 |
0.332 |
|
| 2006 |
Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Cooper G, Markesbery WR. IC-P-040: Structural image data from normals grouped by six-year cognitive outcome: MCI/AD conversion vs. normal Alzheimer's & Dementia. 2: S670-S671. DOI: 10.1016/J.Jalz.2006.05.2245 |
0.367 |
|
| 2006 |
Mendiondo MS, Caban-Holt AM, Saylor CR, Runyons C, Kryscio R, Markesbery WR, Schmitt FA. P3-007: Cognitive screening in the antioxidant AD prevention (PREADVISE) trial: Concordance of MIS and CERAD Alzheimer's & Dementia. 2: S373-S374. DOI: 10.1016/J.Jalz.2006.05.1274 |
0.394 |
|
| 2006 |
Scheff SW, Price DA, Schmitt FA, Schneider JA, Bennett DA, DeKosky ST, Mufson EJ. O1-01-01: Synaptic alterations in inferior temporal lobe in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Alzheimer's & Dementia. 2: S7-S8. DOI: 10.1016/J.Jalz.2006.05.034 |
0.436 |
|
| 2005 |
Caban-Holt A, Bottiggi K, Schmitt FA. Measuring treatment response in Alzheimer's disease clinical trials. Geriatrics. 3-8. PMID 16025769 |
0.322 |
|
| 2005 |
Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 64: 1152-6. PMID 15824339 DOI: 10.1212/01.Wnl.0000156156.13641.Ba |
0.317 |
|
| 2005 |
Schmitt FA, Mendiondo MS, Kryscio RJ, Ashford JW. [O1-05-05]: A Brief Alzheimer's screen for Use in clinical practice Alzheimer's & Dementia. 1: S89-S89. DOI: 10.1016/J.Jalz.2005.06.312 |
0.301 |
|
| 2005 |
Runyons CR, Schmitt FA, Caban-Holt A, Kryscio RJ, Mendiondo MS, Markesbery WR. [P-208]: Antioxidants for the prevention of dementia: Overview of the preadvise trial Alzheimer's & Dementia. 1: S74-S74. DOI: 10.1016/J.Jalz.2005.06.266 |
0.333 |
|
| 2005 |
Kryscio RJ, Salazar JC, Yu L, Mendiondo MS, Schmitt FA. [P-084]: Modeling clinical change from normal aging to MCI, dementia, and death Alzheimer's & Dementia. 1: S34-S34. DOI: 10.1016/J.Jalz.2005.06.158 |
0.358 |
|
| 2005 |
Schmitt FA, Markesbery WR, Kryscio RJ, Caban-Holt A, Cooper G, Smith C, Wekstein D, Davis DG. [P-032]: Neuropathological and memory changes in transitions between normal aging, MCI, and mild Alzheimer's disease Alzheimer's & Dementia. 1: S18-S19. DOI: 10.1016/J.Jalz.2005.06.094 |
0.399 |
|
| 2004 |
Kryscio RJ, Mendiondo MS, Schmitt FA, Markesbery WR. Designing a large prevention trial: statistical issues. Statistics in Medicine. 23: 285-96. PMID 14716729 DOI: 10.1002/Sim.1716 |
0.366 |
|
| 2004 |
Hoffmann M, Schmitt F. Cognitive impairment in isolated subtentorial stroke. Acta Neurologica Scandinavica. 109: 14-24. PMID 14653846 DOI: 10.1034/J.1600-0404.2003.00169.X |
0.352 |
|
| 2004 |
van Dyck C, Cummings J, Schmitt F, Graham S, Olin J, Jin J, Tariot P. P4.028 Functional and behavioral effects of memantinein Alzheimer's disease European Neuropsychopharmacology. 14: S334-S335. DOI: 10.1016/S0924-977X(04)80452-8 |
0.359 |
|
| 2004 |
Schmitt F, Tariot P, Cummings J, Bell J, Jia D, Olin J. P4.021 Robust response to memantine treatmentwhen functional and behavioral results are combined with cognition European Neuropsychopharmacology. 14: S331. DOI: 10.1016/S0924-977X(04)80445-0 |
0.322 |
|
| 2004 |
Wirth Y, Doody R, Schmitt F, Moebius H, Stoeffler A. P4.011 Functional benefit of memantine treatment inpatients with moderate to severe Alzheimer's disease European Neuropsychopharmacology. 14: S327. DOI: 10.1016/S0924-977X(04)80435-8 |
0.38 |
|
| 2004 |
Wirth Y, Doody RS, Schmitt FA, Möbius HJ. P1-375 Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease Neurobiology of Aging. 25: S205. DOI: 10.1016/S0197-4580(04)80687-0 |
0.327 |
|
| 2004 |
Cummings J, Dyck Cv, Schmitt F, Graham SM, Olin JT, Jin J, Tariot PN. P1-315 Functional and behavioral effects of memantine in Alzheimer's disease Neurobiology of Aging. 25: S186. DOI: 10.1016/S0197-4580(04)80628-6 |
0.361 |
|
| 2004 |
Schmitt FA, Tariot P, Cummings J, Bell J, Jia D, Olin J. P1-002 Robust response to memantine treatment when functional and behavioral efficacies are combined with cognition Neurobiology of Aging. 25: S93. DOI: 10.1016/S0197-4580(04)80316-6 |
0.318 |
|
| 2004 |
Schmitt FA, Estus S. Alzheimer's disease genetic susceptibility and causality: What is ApoE's impact? Neurobiology of Aging. 25: 661-662. DOI: 10.1016/J.Neurobiolaging.2004.02.008 |
0.346 |
|
| 2003 |
Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Designing a Brief Alzheimer Screen (BAS). Journal of Alzheimer's Disease : Jad. 5: 391-8. PMID 14646030 DOI: 10.3233/Jad-2003-5506 |
0.432 |
|
| 2003 |
Gaugler JE, Mendiondo M, Smith CD, Schmitt FA. Secondary dementia caregiving and its consequences. American Journal of Alzheimer's Disease and Other Dementias. 18: 300-8. PMID 14569647 DOI: 10.1177/153331750301800505 |
0.321 |
|
| 2003 |
Gaugler JE, Wackerbarth SB, Mendiondo M, Schmitt FA, Smith CD. The characteristics of dementia caregiving onset. American Journal of Alzheimer's Disease and Other Dementias. 18: 97-104. PMID 12708225 DOI: 10.1177/153331750301800208 |
0.318 |
|
| 2003 |
Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 48-53. PMID 12707938 DOI: 10.1002/Ajmg.B.10069 |
0.404 |
|
| 2003 |
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. The New England Journal of Medicine. 348: 1333-41. PMID 12672860 DOI: 10.1056/Nejmoa013128 |
0.303 |
|
| 2002 |
Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Möbius HJ, Stöffler A. Measuring cognition in advanced Alzheimer's disease for clinical trials. Journal of Neural Transmission. Supplementum. 135-48. PMID 12456059 DOI: 10.1007/978-3-7091-6139-5_14 |
0.359 |
|
| 2001 |
Schmitt FA, Wetherby MM, Wekstein DR, Dearth CM, Markesbery WR. Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. The Gerontologist. 41: 716-22. PMID 11723339 DOI: 10.1093/Geront/41.6.716 |
0.324 |
|
| 2001 |
Mendiondo MS, Kryscio RJ, Schmitt FA. Models of progression in AD: Predicting disability and costs Neurology. 57: 943-944. PMID 11571313 DOI: 10.1212/Wnl.57.6.943 |
0.377 |
|
| 2001 |
Ashford JW, Schmitt FA. Modeling the time-course of Alzheimer dementia. Current Psychiatry Reports. 3: 20-8. PMID 11177755 DOI: 10.1007/S11920-001-0067-1 |
0.435 |
|
| 2001 |
Johnson MMS, Wackerbarth SB, Schmitt FA. Revised Memory and Behavior Problems Checklist Clinical Gerontologist. 22: 87-108. DOI: 10.1300/J018V22N03_09 |
0.301 |
|
| 2000 |
Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology. 55: 370-6. PMID 10932270 DOI: 10.1212/Wnl.55.3.370 |
0.318 |
|
| 2000 |
Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Modelling mini mental state examination changes in Alzheimer's disease. Statistics in Medicine. 19: 1607-16. PMID 10844722 DOI: 10.1002/(Sici)1097-0258(20000615/30)19:11/12<1607::Aid-Sim449>3.0.Co;2-O |
0.415 |
|
| 2000 |
Schmitt FA, Miller JP, Kryscio RJ. Promoting interactions with basic scientists and clinicians: summary of the panel session. Statistics in Medicine. 19: 1463-8. PMID 10844711 DOI: 10.1002/(Sici)1097-0258(20000615/30)19:11/12<1463::Aid-Sim438>3.0.Co;2-3 |
0.333 |
|
| 2000 |
Galasko DR, Schmitt FA, Jin S, Saxton J, Bennett D, Sano M, Ferris SH. Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 168. DOI: 10.1016/S0197-4580(00)82096-5 |
0.437 |
|
| 1999 |
Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 53: 1391-6. PMID 10534240 DOI: 10.1212/Wnl.53.7.1391 |
0.314 |
|
| 1999 |
Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. Journal of Neuropathology and Experimental Neurology. 58: 376-88. PMID 10218633 DOI: 10.1097/00005072-199904000-00008 |
0.304 |
|
| 1999 |
Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, Cornett CR, Snowdon DA, Grant FT, Schmitt FA, Donegan SJ, Wekstein DR, Ehmann WD, Markesbery WR. Alzheimer's disease, dental amalgam and mercury. Journal of the American Dental Association (1939). 130: 191-9. PMID 10036842 DOI: 10.14219/Jada.Archive.1999.0168 |
0.355 |
|
| 1999 |
Smith CD, Malcein M, Meurer K, Schmitt FA, Markesbery WR, Pettigrew LC. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 9: 2-9. PMID 9922716 DOI: 10.1111/Jon1999912 |
0.391 |
|
| 1997 |
Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ. The Severe Impairment Battery Alzheimer Disease & Associated Disorders. 11: 51-56. DOI: 10.1097/00002093-199700112-00008 |
0.414 |
|
| 1996 |
Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, Reisberg B, Schmitt FA. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. Journal of Geriatric Psychiatry and Neurology. 9: 176-80. PMID 8970010 DOI: 10.1177/089198879600900404 |
0.406 |
|
| 1996 |
Greiner PA, Snowdon DA, Schmitt FA. The loss of independence in activities of daily living: the role of low normal cognitive function in elderly nuns. American Journal of Public Health. 86: 62-6. PMID 8561244 DOI: 10.2105/Ajph.86.1.62 |
0.342 |
|
| 1996 |
Ashford JW, Schmitt FA, Kumar V. Diagnosis of Alzheimer's Disease Psychiatric Annals. 26: 262-268. DOI: 10.3928/0048-5713-19960501-06 |
0.378 |
|
| 1995 |
Ashford JW, Shan M, Butler S, Rajasekar A, Schmitt FA. Temporal quantification of Alzheimer's disease severity: 'time index' model. Dementia (Basel, Switzerland). 6: 269-80. PMID 8528374 DOI: 10.1159/000106958 |
0.422 |
|
| 1994 |
Marson DC, Schmitt FA, Ingram KK, Harrell LE. Determining the competency of Alzheimer patients to consent to treatment and research. Alzheimer Disease and Associated Disorders. 8: 5-18. PMID 7695856 DOI: 10.1097/00002093-199400000-00002 |
0.374 |
|
| 1994 |
Blonder LX, Kort ED, Schmitt FA. Conversational Discourse in Patients with Alzheimer's Disease Journal of Linguistic Anthropology. 4: 50-71. DOI: 10.1525/Jlin.1994.4.1.50 |
0.335 |
|
| 1993 |
Logue PE, Tupler LA, D'Amico CJ, Schmitt FA. The Neurobehavioral Cognitive Status Examination: psychometric properties in use with psychiatric inpatients. Journal of Clinical Psychology. 49: 80-89. PMID 8425938 DOI: 10.1002/1097-4679(199301)49:1<80::Aid-Jclp2270490111>3.0.Co;2-Z |
0.379 |
|
| 1993 |
Lanska DJ, Schmitt FA, Stewart JM, Howe JN. Telephone-Assessed Mental State. Dementia (Basel, Switzerland). 4: 117-9. PMID 8358512 DOI: 10.1159/000107307 |
0.381 |
|
| 1992 |
DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Annals of Neurology. 32: 625-32. PMID 1360195 DOI: 10.1002/Ana.410320505 |
0.409 |
|
| 1992 |
Schmitt FA, Shih W, DeKosky ST. Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. Neuropsychology. 6: 159-171. DOI: 10.1037/0894-4105.6.2.159 |
0.305 |
|
| 1991 |
Berry DT, Allen RS, Schmitt FA. Rey-Osterrieth complex figure: Psychometric characteristics in a geriatric sample Clinical Neuropsychologist. 5: 143-153. DOI: 10.1080/13854049108403298 |
0.335 |
|
| 1990 |
DeKosky ST, Shih WJ, Schmitt FA, Coupal J, Kirkpatrick C. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Disease and Associated Disorders. 4: 14-23. PMID 2317335 DOI: 10.1097/00002093-199040100-00002 |
0.419 |
|
| 1989 |
Schmitt FA, Ranseen JD, DeKosky ST. Cognitive Mental Status Examinations Clinics in Geriatric Medicine. 5: 545-564. DOI: 10.1016/S0749-0690(18)30670-0 |
0.328 |
|
| 1989 |
Schmitt F. Neuropsychological correlates of Single Photon Emission Tomography (SPECT) in Alzheimer's disease Archives of Clinical Neuropsychology. 4: 117. DOI: 10.1016/0887-6177(89)90067-X |
0.32 |
|
| 1988 |
Farber JF, Schmitt FA, Logue PE. Predicting intellectual level from the Mini-Mental State Examination. Journal of the American Geriatrics Society. 36: 509-10. PMID 3372930 DOI: 10.1111/J.1532-5415.1988.Tb04020.X |
0.346 |
|
| 1988 |
Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. The New England Journal of Medicine. 319: 1573-8. PMID 3059187 DOI: 10.1056/Nejm198812153192404 |
0.348 |
|
| Show low-probability matches. |